NLS Pharmaceutics receives non-compliance letter from Nasdaq

• NLS Pharmaceutics (NASDAQ:NLSP) on Friday announced that it has received a letter from Nasdaq notifying the company that it is no longer in compliance with the minimum stockholders' equity requirement for continued listing.
• Source: Press Release

More on NLS Pharmaceutics

• Seeking Alpha’s Quant Rating on NLS Pharmaceutics
• Historical earnings data for NLS Pharmaceutics
• Financial information for NLS Pharmaceutics